Dilated cardiomyopathy differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Line 14: Line 14:
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Clinical Presentation
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Clinical Presentation
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Laboratory Findings
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Laboratory Findings
!Electrocardiogram
!Echocardiography
|-
|-
|[[Acute coronary syndromes|Acute Coronary Syndrome]]
|[[Acute coronary syndromes|Acute Coronary Syndrome]]
Line 26: Line 28:
* [[Nausea and vomiting|Nausea]], vomiting, and [[Perspiration|sweating]]
* [[Nausea and vomiting|Nausea]], vomiting, and [[Perspiration|sweating]]
|
|
* Echocardiogram: [[ST segment]] and T wave changes, pathological Q waves.
* Elevated blood [[troponin]] levels (after 6 hours of attack onset)
* Elevated blood [[troponin]] levels (after 6 hours of attack onset)
* Elevated blood [[CK-MB]] levels
* Elevated blood [[CK-MB]] levels
|
* [[ST segment]] changes
* T wave changes
* Pathological Q waves.
|
|-
|-
|Acute [[Pericarditis]]
|Acute [[Pericarditis]]
Line 42: Line 50:
* [[Fever]] (for inflammatory causes)
* [[Fever]] (for inflammatory causes)
|
|
* Echocardiogram: Slight ST segment elevation in several leads & diffuse T wave inversion
*[[Complete blood count|CBC]]: Increased WBCs count
* [[Complete blood count|CBC]]: Increased WBCs count
* Modest increase in [[CK-MB]]
* Modest increase in [[CK-MB]]
* Elevated [[C-reactive protein|CRP]] levels.
* Elevated [[C-reactive protein|CRP]] levels.
|
* Slight ST segment elevation in several leads
* Diffuse T wave inversion
|
|-
|-
|[[Amphetamine]]/[[Cocaine]]  
|[[Amphetamine]]/[[Cocaine]]  
Line 60: Line 72:
* Elevated serum CK ([[rhabdomyolysis]])
* Elevated serum CK ([[rhabdomyolysis]])
* Impaired electrolytes levels
* Impaired electrolytes levels
|
|
|-
|-
|Arrhythmogenic right ventricular  
|Arrhythmogenic right ventricular  
Line 74: Line 88:
* Electrocardiogram
* Electrocardiogram
* Imaging modalities as 2D [[echocardiography]] and MRI.
* Imaging modalities as 2D [[echocardiography]] and MRI.
|
|
|-
|-
|Wet [[Beriberi]]
|Wet [[Beriberi]]
Line 89: Line 105:
* Reduced urinary thiamine
* Reduced urinary thiamine
* Reduced erythrocyte [[transketolase]]  and [[thiamine pyrophosphate]] activities.
* Reduced erythrocyte [[transketolase]]  and [[thiamine pyrophosphate]] activities.
|
|
|-
|-
|[[Cardiac tamponade|Cardiac Tamponade]]
|[[Cardiac tamponade|Cardiac Tamponade]]
Line 104: Line 122:
* Subacute tamponade: Peripheral [[edema]] with gradual progression to the aforementioned clinical picture.
* Subacute tamponade: Peripheral [[edema]] with gradual progression to the aforementioned clinical picture.
|
|
* Echocardiography to score the [[European society of cardiology|European Society of Cardiology]] (ESC) Working Group on Myocardial and Pericardial Diseases
* Increased serum [[Creatine kinase|CK-MB]] and [[troponin]]
* Increased serum [[Creatine kinase|CK-MB]] and [[troponin]]
* Cause-related investigations as serum inflammatory markers, diagnostic pericardiocentesis, and [[Gallium Citrate Ga 67|Gallium]] 67 imaging.
* Cause-related investigations as serum inflammatory markers, diagnostic pericardiocentesis, and [[Gallium Citrate Ga 67|Gallium]] 67 imaging.
|
|Echocardiography to score the [[European society of cardiology|European Society of Cardiology]] (ESC) Working Group on Myocardial and Pericardial Diseases
|-
|-
|[[Hyperthyroidism]]
|[[Hyperthyroidism]]
Line 125: Line 144:
* [[Thyroid-stimulating hormone|TSH]]: Reduced in 1ry and Elevated in 2ry hyperthyroidism.
* [[Thyroid-stimulating hormone|TSH]]: Reduced in 1ry and Elevated in 2ry hyperthyroidism.
* Thyroid stimulating antibodies: Elevated only in [[Graves' disease|Grave's disease]]
* Thyroid stimulating antibodies: Elevated only in [[Graves' disease|Grave's disease]]
|
|
|-
|-
|[[Hypertrophic cardiomyopathy|Hypertrophic Cardiomyopathy]]
|[[Hypertrophic cardiomyopathy|Hypertrophic Cardiomyopathy]]
Line 145: Line 166:


* Electrocardiogram
* Electrocardiogram
* Echocardiography according to ACCF/[[American Heart Association|AHA]] Guideline for the Diagnosis and Treatment of [[Hypertrophic cardiomyopathy|Hypertrophic Cardiomyopathy]]
*  
|
|Echocardiography according to ACCF/[[American Heart Association|AHA]] Guideline for the Diagnosis and Treatment of [[Hypertrophic cardiomyopathy|Hypertrophic Cardiomyopathy]]
|-
|-
|[[Noncompaction cardiomyopathy|Left ventricular noncompaction]]
|[[Noncompaction cardiomyopathy|Left ventricular noncompaction]]
Line 161: Line 184:
* Echocardiography
* Echocardiography
* Steady-state free precession MRI, showing prominent trabeculations and a non-compacted to compacted (NC/C) myocardium ratio > 2.3
* Steady-state free precession MRI, showing prominent trabeculations and a non-compacted to compacted (NC/C) myocardium ratio > 2.3
|
|
|-
|-
|[[Myocarditis]]
|[[Myocarditis]]
Line 183: Line 208:
* Serological markers such as [[Fas]], [[Fas ligand]], [[interleukin]]-10 or antimyosin autoantibodies
* Serological markers such as [[Fas]], [[Fas ligand]], [[interleukin]]-10 or antimyosin autoantibodies
* Viral antibody titres or autoantibodies (to reach the cause)
* Viral antibody titres or autoantibodies (to reach the cause)
|
|
|-
|-
|[[Restrictive Cardiomyopathies|Restrictive]] Cardiomyopathy
|[[Restrictive Cardiomyopathies|Restrictive]] Cardiomyopathy
Line 195: Line 222:
*[[Kussmaul's sign|Kussmaul sign]]
*[[Kussmaul's sign|Kussmaul sign]]
*S3 and S4 gallops
*S3 and S4 gallops
|Diagnosis is based on:
|
 
* Electrocardiogram: Low [[QRS complex|QRS]] voltages and conduction abnormalities.
* Echocardiogram: Wall and valvular thickening and sparkling myocardium.
* To verify the cause: measuring [[Iron overload disorder|iron overload]] and [[myocardial biopsy]]
* To verify the cause: measuring [[Iron overload disorder|iron overload]] and [[myocardial biopsy]]
|
* Low [[QRS complex|QRS]] voltages
* Conduction abnormalities.
|Wall and valvular thickening and sparkling myocardium.
|}
|}



Revision as of 14:32, 23 December 2019

Dilated cardiomyopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Classification

Causes

Differentiating Dilated cardiomyopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Dilated cardiomyopathy differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Dilated cardiomyopathy differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Dilated cardiomyopathy differential diagnosis

CDC on Dilated cardiomyopathy differential diagnosis

Dilated cardiomyopathy differential diagnosis in the news

Blogs on Dilated cardiomyopathy differential diagnosis

Directions to Hospitals Treating Dilated cardiomyopathy

Risk calculators and risk factors for Dilated cardiomyopathy differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdelrahman Ibrahim Abushouk, MD[2]

Overview

Dilated cardiomyopathy should be differentiated from other causes of cardiac dysfunction, in particular acute coronary syndrome, other cardiomyopathies (hypertrophic, restrictive, and ARVC/D), myocarditis, pericarditis, and cardiac toxicities.

Differentiating Dilated Cardiomyopathy from other Diseases

Dilated cardiomyopathy should be differentiated from other causes of cardiac dysfunction, in particular acute coronary syndrome, other cardiomyopathies (hypertrophic, restrictive, and ARVC/D), myocarditis, pericarditis, and cardiac toxicities.[1][2][3][4]

Disorders Etiology Clinical Presentation Laboratory Findings Electrocardiogram Echocardiography
Acute Coronary Syndrome
  • Elevated blood troponin levels (after 6 hours of attack onset)
  • Elevated blood CK-MB levels
  • T wave changes
  • Pathological Q waves.
Acute Pericarditis
  • CBC: Increased WBCs count
  • Modest increase in CK-MB
  • Elevated CRP levels.
  • Slight ST segment elevation in several leads
  • Diffuse T wave inversion
Amphetamine/Cocaine

Cardiomyopathy

  • Illicit drug use
  • Drug and toxicology screen
  • Elevated serum CK (rhabdomyolysis)
  • Impaired electrolytes levels
Arrhythmogenic right ventricular

cardiomyopathy (ARVC/D)

Diagnostic criteria are based on:
Wet Beriberi
  • Inadequate thiamine intake (rice-based foods, alcoholism, and malnutrition)
  • Increased thiamine loss (protracted vomiting)
  • Inadequate absorption (after bariatric surgery or genetic mutation)
Cardiac Tamponade
  • Acute tamponade: Cardiogenic shock, hypotension, cold extremities, peripheral cyanosis, and decreased urine output.
  • Subacute tamponade: Peripheral edema with gradual progression to the aforementioned clinical picture.
  • Increased serum CK-MB and troponin
  • Cause-related investigations as serum inflammatory markers, diagnostic pericardiocentesis, and Gallium 67 imaging.
Echocardiography to score the European Society of Cardiology (ESC) Working Group on Myocardial and Pericardial Diseases
Hyperthyroidism
  • Elevated T3 and T4 hormones
  • TSH: Reduced in 1ry and Elevated in 2ry hyperthyroidism.
  • Thyroid stimulating antibodies: Elevated only in Grave's disease
Hypertrophic Cardiomyopathy The diagnosis is based on
  • Electrocardiogram
Echocardiography according to ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Left ventricular noncompaction Diagnosis can be based on:
  • Echocardiography
  • Steady-state free precession MRI, showing prominent trabeculations and a non-compacted to compacted (NC/C) myocardium ratio > 2.3
Myocarditis
Restrictive Cardiomyopathy Systemic diseases, such as
  • Low QRS voltages
  • Conduction abnormalities.
Wall and valvular thickening and sparkling myocardium.

References

  1. Amosova EN (1992). "[Differential diagnosis of dilated cardiomyopathy]". Klin Med (Mosk). 70 (3–4): 14–9. PMID 1507837.
  2. Schultheiss HP, Fairweather D, Caforio ALP, Escher F, Hershberger RE, Lipshultz SE; et al. (2019). "Dilated cardiomyopathy". Nat Rev Dis Primers. 5 (1): 32. doi:10.1038/s41572-019-0084-1. PMID 31073128.
  3. Gurevich MA, Gordienko BV (2003). "[Dilated and ischemic cardiomyopathy: differential diagnosis]". Klin Med (Mosk). 81 (9): 68–71. PMID 14598597.
  4. Gurevich MA, Gordienko BV (2003). "[Dilated and ischemic cardiomyopathy: differential diagnosis]". Klin Med (Mosk). 81 (9): 68–71. PMID 14598597.


Template:WH Template:WS